Polyphor: Global No. 2 in the 2018 Biopharmaceuticals Antimicrobial Resistance Benchmark published by the Access to Medicine Foundation

January 23, 2018
Polyphor Ltd

January 23, 2018 - Polyphor has been selected by the Access to Medicine Foundation as one of the leading biopharmaceutical companies in the area of research and development against antimicrobial resistance, as published today in the first Antimicrobial Resistance Benchmark at the 2018 World Economic Forum (WEF) Annual Meeting in Davos, Switzerland.


Press Release available here: